BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35921211)

  • 1. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
    Stasikowska-Kanicka O; WÄ…growska-Danilewicz M; Danilewicz M
    APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
    Greeshma LR; Joseph AP; Sivakumar TT; Raghavan Pillai V; Vijayakumar G
    Sci Rep; 2023 Dec; 13(1):21698. PubMed ID: 38066025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
    Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
    Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
    Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
    J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Pathomics-Based Model for the Prediction of Malignant Transformation in Oral Leukoplakia.
    Cai X; Li L; Yu F; Guo R; Zhou X; Zhang F; Zhang H; Zhang J; Li T
    Lab Invest; 2023 Aug; 103(8):100173. PubMed ID: 37164265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
    Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
    Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
    Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-exosome-mediated matrix metalloproteinase 1 participates in oral leukoplakia and carcinogenesis by inducing angiogenesis.
    Li S; Han Y; Lu M; Liu Z; Jin J; Guo Q; Wang Y; Liu H
    J Oral Pathol Med; 2022 Aug; 51(7):638-648. PubMed ID: 35792829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
    Wang QM; Huang XY; Guan WQ
    Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
    Ma SR; Liu JF; Jia R; Deng WW; Jia J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
    Lan Q; Zhang C; Hua H; Hu X
    BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma.
    Wang X; Zhang J; Zhou G
    J Oral Pathol Med; 2021 Apr; 50(4):362-370. PubMed ID: 33187013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
    Takahashi H; Sakakura K; Arisaka Y; Tokue A; Kaira K; Tada H; Higuchi T; Okamoto A; Tsushima Y; Chikamatsu K
    Anticancer Res; 2019 Jun; 39(6):3039-3046. PubMed ID: 31177146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 blockade prevents the progression of oral carcinogenesis.
    Dong Y; Wang Z; Mao F; Cai L; Dan H; Jiang L; Zeng X; Li T; Zhou Y; Chen Q
    Carcinogenesis; 2021 Jun; 42(6):891-902. PubMed ID: 33993220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
    Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
    Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
    Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and clinicopathological status of PD-L1 expression and CD8+ TILs in oral squamous cell cancer patients with or without traditional risk factors.
    Soopanit T; Laokulrath N; Chayopasakul V; Pongsapich W
    Head Neck; 2023 Apr; 45(4):1017-1025. PubMed ID: 36811208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.